C. Elegans As a Test System to Study Relevant Compounds That Contribute to the Specific Health-related Effects of Different Cannabis Varieties

Overview

Journal J Cannabis Res

Date 2022 Oct 2

PMID 36184617

Authors

Monique van Es-Remers

Jesus Arellano Spadaro

Eefje Poppelaars

Hye Kyong Kim

Marieke van Haaster

Marcel de Wit

Eva Iliopoulou

Marjolein Wildwater

Henrie Korthout

Affiliations

Soon will be listed here.

Abstract

Background: The medicinal effects of cannabis varieties on the market cannot be explained solely by the presence of the major cannabinoids Δ-tetrahydrocannabinol (THC) and cannabidiol (CBD). Evidence for putative entourage effects caused by other compounds present in cannabis is hard to obtain due to the subjective nature of patient experience data. Caenorhabditis elegans (C. elegans) is an objective test system to identify cannabis compounds involved in claimed health and entourage effects.

Methods: From a medicinal cannabis breeding program by MariPharm BV, the Netherlands a set of 12 varieties were selected both THC rich varieties as well as CBD rich varieties. A consecutive extraction process was applied resulting in a non-polar (cannabinoid-rich) and polar (cannabinoid-poor) extract of each variety. The test model C. elegans was exposed to these extracts in a broad set of bioassays for appetite control, body oscillation, motility, and nervous system function.

Results: Exposing C. elegans to extracts with a high concentration of cannabinoids (> 1 μg/mL) reduces the life span of C. elegans dramatically. Exposing the nematodes to the low-cannabinoid (< 0.005 μg/mL) polar extracts, however, resulted in significant effects with respect to appetite control, body oscillation, motility, and nervous system-related functions in a dose-dependent and variety-dependent manner.

Discussion: C. elegans is a small, transparent organism with a complete nervous system, behavior and is due to its genetic robustness and short life cycle highly suitable to unravel entourage effects of Cannabis compounds. Although C. elegans lacks an obvious CB1 and CB2 receptor it has orthologs of Serotonin and Vanilloid receptor which are also involved in (endo)cannabinoid signaling.

Conclusion: By using C. elegans, we were able to objectively distinguish different effects of different varieties despite the cannabinoid content. C. elegans seems a useful test system for studying entourage effects, for targeted medicinal cannabis breeding programs and product development.

Citing Articles

Sample Preparation of Caenorhabditis elegans for GC-MS-Based Metabolomics in Toxicity Assessment.

Spadaro J, Wildwater M, Korthout H, Kim H Methods Mol Biol. 2025; 2895:271-297.

PMID: 39885036 DOI: 10.1007/978-1-0716-4350-1_18.

Cannabinoids and healthy ageing: the potential for extending healthspan and lifespan in preclinical models with an emphasis on Caenorhabditis elegans.

Wang Z, Arnold J Geroscience. 2024; 46(6):5643-5661.

PMID: 38696056 PMC: 11493940. DOI: 10.1007/s11357-024-01162-8.

References

Apfeld J, Alper S . What Can We Learn About Human Disease from the Nematode C. elegans?. Methods Mol Biol. 2018; 1706:53-75. PMC: 6391162. DOI: 10.1007/978-1-4939-7471-9_4. View

Aviz-Amador A, Contreras-Puentes N, Mercado-Camargo J . Virtual screening using docking and molecular dynamics of cannabinoid analogs against CB and CB receptors. Comput Biol Chem. 2021; 95:107590. DOI: 10.1016/j.compbiolchem.2021.107590. View

Bailone R, Fukushima H, de Aguiar L, Borra R . The endocannabinoid system in zebrafish and its potential to study the effects of Cannabis in humans. Lab Anim Res. 2022; 38(1):5. PMC: 8862295. DOI: 10.1186/s42826-022-00116-5. View

Chao M, Komatsu H, Fukuto H, Dionne H, Hart A . Feeding status and serotonin rapidly and reversibly modulate a Caenorhabditis elegans chemosensory circuit. Proc Natl Acad Sci U S A. 2004; 101(43):15512-7. PMC: 524441. DOI: 10.1073/pnas.0403369101. View

Cogan P . The 'entourage effect' or 'hodge-podge hashish': the questionable rebranding, marketing, and expectations of cannabis polypharmacy. Expert Rev Clin Pharmacol. 2020; 13(8):835-845. DOI: 10.1080/17512433.2020.1721281. View

de Almeida D, Devi L . Diversity of molecular targets and signaling pathways for CBD. Pharmacol Res Perspect. 2020; 8(6):e00682. PMC: 7652785. DOI: 10.1002/prp2.682. View

de la Fuente A, Zamberlan F, Sanchez Ferran A, Carrillo F, Tagliazucchi E, Pallavicini C . Relationship among subjective responses, flavor, and chemical composition across more than 800 commercial cannabis varieties. J Cannabis Res. 2021; 2(1):21. PMC: 7819481. DOI: 10.1186/s42238-020-00028-y. View

Di Marzo V, Piscitelli F . The Endocannabinoid System and its Modulation by Phytocannabinoids. Neurotherapeutics. 2015; 12(4):692-8. PMC: 4604172. DOI: 10.1007/s13311-015-0374-6. View

Eliezer Y, Deshe N, Hoch L, Iwanir S, Pritz C, Zaslaver A . A Memory Circuit for Coping with Impending Adversity. Curr Biol. 2019; 29(10):1573-1583.e4. PMC: 6538972. DOI: 10.1016/j.cub.2019.03.059. View

10.

Frandsen J, Narayanasamy P . Effect of Cannabidiol on the Neural Glyoxalase Pathway Function and Longevity of Several Strains Including a Alzheimer's Disease Model. ACS Chem Neurosci. 2022; 13(8):1165-1177. DOI: 10.1021/acschemneuro.1c00667. View

11.

Green C, Lamming D, Fontana L . Molecular mechanisms of dietary restriction promoting health and longevity. Nat Rev Mol Cell Biol. 2021; 23(1):56-73. PMC: 8692439. DOI: 10.1038/s41580-021-00411-4. View

12.

Huestis M, Henningfield J, Cone E . Blood cannabinoids. I. Absorption of THC and formation of 11-OH-THC and THCCOOH during and after smoking marijuana. J Anal Toxicol. 1992; 16(5):276-82. DOI: 10.1093/jat/16.5.276. View

13.

Ishita Y, Chihara T, Okumura M . Serotonergic modulation of feeding behavior in Caenorhabditis elegans and other related nematodes. Neurosci Res. 2019; 154:9-19. DOI: 10.1016/j.neures.2019.04.006. View

14.

Kapahi P, Kaeberlein M, Hansen M . Dietary restriction and lifespan: Lessons from invertebrate models. Ageing Res Rev. 2016; 39:3-14. PMC: 5476520. DOI: 10.1016/j.arr.2016.12.005. View

15.

Koltai H, Namdar D . Cannabis Phytomolecule 'Entourage': From Domestication to Medical Use. Trends Plant Sci. 2020; 25(10):976-984. DOI: 10.1016/j.tplants.2020.04.007. View

16.

Land M, Toth M, MacNair L, Vanapalli S, Lefever T, Peters E . Effect of Cannabidiol on the Long-Term Toxicity and Lifespan in the Preclinical Model . Cannabis Cannabinoid Res. 2021; 6(6):522-527. PMC: 8713279. DOI: 10.1089/can.2020.0103. View

17.

Lopez-Gresa M, Lison P, Kim H, Choi Y, Verpoorte R, Rodrigo I . Metabolic fingerprinting of Tomato Mosaic Virus infected Solanum lycopersicum. J Plant Physiol. 2012; 169(16):1586-96. DOI: 10.1016/j.jplph.2012.05.021. View

18.

Lucas C, Galettis P, Schneider J . The pharmacokinetics and the pharmacodynamics of cannabinoids. Br J Clin Pharmacol. 2018; 84(11):2477-2482. PMC: 6177698. DOI: 10.1111/bcp.13710. View

19.

Maayah Z, Takahara S, Ferdaoussi M, Dyck J . The anti-inflammatory and analgesic effects of formulated full-spectrum cannabis extract in the treatment of neuropathic pain associated with multiple sclerosis. Inflamm Res. 2020; 69(6):549-558. DOI: 10.1007/s00011-020-01341-1. View

20.

Mackie K . Cannabinoid receptors: where they are and what they do. J Neuroendocrinol. 2008; 20 Suppl 1:10-4. DOI: 10.1111/j.1365-2826.2008.01671.x. View